What is Monarch PCM?
Monarch PCM operates as a specialized provider of pharmaceutical serialization services, ensuring rigorous adherence to the Drug Supply Chain Security Act (DSCSA) of 2013. The company provides essential track and trace capabilities that enhance transparency across the global drug distribution network. By mitigating risks associated with product diversion, theft, and counterfeiting, Monarch PCM serves as a vital partner for pharmaceutical manufacturers and distributors seeking to optimize shipping accuracy and streamline recall management processes. Their platform acts as a foundational layer for supply chain integrity, enabling stakeholders to maintain compliance while improving operational efficiency in a complex regulatory environment.
How much funding has Monarch PCM raised?
Monarch PCM has raised a total of $1.2M across 2 funding rounds:
Debt
$350K
Debt
$842K
Debt (2020): $350K with participation from PPP
Debt (2021): $842K led by PPP
Key Investors in Monarch PCM
PPP
Public-Private Partnership
What's next for Monarch PCM?
With the recent infusion of capital, Monarch PCM is poised to accelerate its enterprise-level growth strategy. The focus will likely shift toward scaling its technological architecture to accommodate increasing demand for real-time visibility and data-driven supply chain management. As the pharmaceutical industry faces heightened scrutiny regarding product provenance, Monarch PCM is well-positioned to capture additional market share by enhancing its serialization software suite. Future initiatives will likely prioritize the integration of advanced analytics to further reduce operational friction and bolster the security of the pharmaceutical cold chain, ensuring that the company remains at the forefront of regulatory technology innovation.
See full Monarch PCM company page
